NCT07713602: Study to Assess Safety and Clinical Responses With Coartem® Baby Dispersible Tablets in Paediatric Patients Weighing 2 to <5 kg With Uncomplicated Malaria
- State
- Not started
- Phase
- Phase 4
- People
- 20 planned
- Started
- 18 Jun 2027
- Primary completion
- 4 May 2028
- Arms
- Coartem® Baby (5mg/60mg)
- Results
- None posted
- 20 Jul 2026: Trial registered